Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance.
The week at Retraction Watch featured:
- A review of a French hydroxychloroquine study that found it was “fully irresponsible“
- An expression of concern for a paper that claimed the Koran had predicted the Higgs Boson
- An infectious disease researcher that a U.S. federal watchdog said had “recklessly” faked data in grants worth millions
- The retraction of a big Nature study on a tiny “dinosaur”
- An author retracting a Nature commentary because of concerns about the section’s sponsorship
Our list of retracted or withdrawn COVID-19 papers is up to 25.
Here’s what was happening elsewhere:
- A tool for detecting image duplication sounds potentially useful, with lots of room for improvement. The reaction on PubPeer reminds us of what happened with statcheck in 2016.
- “Plagiarism of Wikipedia articles in the scholarly literature has received little if any attention thus far.” Five cases. And two more.
- “It’s Time to Get Serious About Research Fraud.”
- “Fake journals in the age of fake news: the dangers of predatory publishing.”
- “Jargon and metrics for evaluation: Are they valid or instead promote questionable practices?”
- “The vast majority of medical journals now allow articles to appear as preprints before they are peer reviewed and officially published, a new study finds.”
- “Will the pandemic change the research culture or how results are made available in the future?”
- “The Kuomintang (KMT) candidate for the Kaohsiung mayoral by-election Li Mei-jhen (李眉蓁) has been accused of plagiarizing speech notes and an academic paper for most of her master’s thesis.”
- “A visiting Chinese researcher at Stanford University has been charged with visa fraud for allegedly hiding her employment by the Chinese military.”
- “Publishers: let transgender scholars correct their names.”
- “In the long run, science tends to be self-correcting, because fraudulent or invalid research may be retracted, and mistaken hypotheses or theories may be refuted by new data or experiments. However, this self-correcting process may take years or even decades, and the public often cannot wait for science to produce the correct solution to a problem, especially during a health crisis like the COVID-19 pandemic.”
- “The best time to argue about what a replication means? Before you do it.”
- “Are replication rates the same across academic fields?”
- “We keep expecting to receive high quality articles from those who argue for this as of yet non-evidence based therapy, clarifying the scientific rationale behind this preference.”
- “Pakistan’s publication counting adds up to too little.”
- “How Often Do the Iranian Medical Journal Editors-in-Chief Publish in Their Own Journals?”
- “How to Identify Flawed Research Before It Becomes Dangerous.” (Michael Eisen, Robert Tibishrani)
- The University of Southern California paid its former president more than $7.6 million when he stepped down.
- “That’s what it’s like to fight back against a prevailing dogma with new evidence, said Vig — it’s wearying.”
- “Matovic: I Committed Plagiarism Unknowingly, I’ll Retire if Ousted.”
- “To any journalists reading this who cover COVID-19 science: please keep an eye on Retraction Watch’s list of retracted or withdrawn papers. If something seems too good to be true, push on it.” Here’s that list.
- “The only way to solve this problem and to protect patients is for the Health Minister to insist that all doctors who wish to act as journal editors and peer reviewers do so with their name and qualifications attached to the final published paper.”
Like Retraction Watch? You can make a tax-deductible contribution to support our work, follow us on Twitter, like us on Facebook, add us to your RSS reader, or subscribe to our daily digest. If you find a retraction that’s not in our database, you can let us know here. For comments or feedback, email us at [email protected].
Sadly for trans authors, I don’t think it’s possible for them to divorce their previous deadname from their current name. The author objects for example to changing metadata only without changing the PDF, but changing metadata requires an update, especially if a publisher is a Crossmark participant (https://www.crossref.org/services/crossmark/). The update is important to help readers cite the author’s current name but will out the author if registered. It seems that trans authors cannot be satisfied here – the past cannot be changed without linking it to the present.
That is the beauty of always using an ORCID or similar universal designation. You can keep your whole line of research intact even if your name changes as you go along. Sadly, I agree it is probably not possible to go back and change everything (and may not be legal in many countries because the old name was in fact their legal name at the time) but at least they can go forward without losing any citations, publication credits, or academic reputation from the past.